Zacks Investment Research Lowers Vitamin Shoppe, Inc (VSI) to Sell
Vitamin Shoppe, Inc (NYSE:VSI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday.
According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “
A number of other research firms have also recently commented on VSI. Morgan Stanley set a $8.00 price objective on Vitamin Shoppe and gave the stock a “hold” rating in a research report on Thursday, August 10th. Barclays PLC reiterated an “equal weight” rating and set a $13.00 price objective (down previously from $24.00) on shares of Vitamin Shoppe in a research report on Sunday, May 14th. BidaskClub cut Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Gabelli cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Three research analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company. The company presently has an average rating of “Hold” and an average price target of $15.71.
Shares of Vitamin Shoppe (VSI) traded down 5.43% on Tuesday, hitting $6.10. 498,112 shares of the stock traded hands. Vitamin Shoppe has a 12 month low of $5.75 and a 12 month high of $28.56. The firm’s 50 day moving average is $10.35 and its 200-day moving average is $15.72. The company’s market cap is $141.71 million.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. The company had revenue of $304.84 million for the quarter, compared to analysts’ expectations of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.55 EPS. Equities analysts predict that Vitamin Shoppe will post $0.98 earnings per share for the current year.
WARNING: This report was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/08/15/zacks-investment-research-lowers-vitamin-shoppe-inc-vsi-to-sell.html.
A number of hedge funds have recently bought and sold shares of the stock. Comerica Bank boosted its stake in Vitamin Shoppe by 37.8% in the first quarter. Comerica Bank now owns 35,339 shares of the specialty retailer’s stock valued at $689,000 after buying an additional 9,685 shares during the period. Norges Bank acquired a new stake in Vitamin Shoppe during the fourth quarter valued at approximately $6,444,000. Principal Financial Group Inc. boosted its stake in Vitamin Shoppe by 3.7% in the first quarter. Principal Financial Group Inc. now owns 181,564 shares of the specialty retailer’s stock valued at $3,659,000 after buying an additional 6,408 shares during the period. First Trust Advisors LP acquired a new stake in Vitamin Shoppe during the first quarter valued at approximately $549,000. Finally, LSV Asset Management boosted its stake in Vitamin Shoppe by 109.4% in the first quarter. LSV Asset Management now owns 76,648 shares of the specialty retailer’s stock valued at $1,544,000 after buying an additional 40,048 shares during the period.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.